New 4-thiazolidinone-based molecules Les-2769 and Les-3266 as possible PPARγ modulators
Open Access
- 5 August 2022
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 128, 106075
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- PPAR and Oxidative Stress: Con() Catenating NRF2 and FOXOPPAR Research, 2012
- Fused Thiopyrano[2,3-d]thiazole Derivatives as Potential Anticancer AgentsScientia Pharmaceutica, 2012
- Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific groupBiopolymers and Cell, 2011
- Role of NF-κB and PPAR-γ in lung inflammation induced by monocyte-derived microparticlesEuropean Respiratory Journal, 2010
- Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor γCell Research, 2009
- Modulation of cell growth and PPARγ expression in human colorectal cancer cell lines by ciglitazoneExperimental and Toxicologic Pathology, 2008
- An Alternative Method for the Evaluation of Docking Performance: RSR vs RMSDJournal of Chemical Information and Modeling, 2008
- Differential effects of PPARγ agonists on the metabolic properties of gliomas and astrocytesNeuroscience Letters, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- Ciglitazone induces early cellular proliferation and NF-κB transcriptional activity in colon cancer cells through p65 phosphorylationThe International Journal of Biochemistry & Cell Biology, 2005